skip to main content
Close Icon We use cookies to improve your website experience.  To learn about our use of cookies and how you can manage your cookie settings, please see our Cookie Policy.  By continuing to use the website, you consent to our use of cookies.
Informa pharma logo

Pharma Intelligence is part of the Informa Intelligence Division of Informa PLC

This is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Pharma Intelligence Logo
Search Icon Pharma Report StoreRecommendationsProduct loginProductLogin
Global Search Configuration
text

Brexit has major implications for pharmaceutical and medtech companies in the UK, EU and around the world. The full impact may not be known for months or years, but regulatory alignment, research funding and product supply chains are all at risk. As the clock ticks down on the deadlines, follow our in-depth coverage to find out what the future holds for your business.

text

What Brexit Means for Pharma and Medtech

What Brexit Means for Pharma and Medtech

Brexit Timeline

March 2016

Britain decides to leave the EU

31st January 2020

UK leaves the EU

March 2020

UK and EU begin talks on future trade deal

June | July 2020

UK has until June 30 to request transition period extension

October 2020

European Council Will Meet

31st December 2020

End of transition period if not extended

January 2021

Post-Brexit Coverage

Left Column Header Image

Pharma Brexit Implications

Magnified Glass Image
Pharma Brexit News and Insight Coverage

Outlook for UK drug regulation and trade as talks progress on the future UK-EU relationship and a UK trade deal with the US.

Access our Pharma Brexit coverage

Brexit news page

Medtech Brexit Implications

Magnified Glass Image
Medtech Brexit News and Insight Coverage
Regulatory implications of Brexit in the UK and EU, including the new medtech legislation, and the impact of Brexit on businesses worldwide.

Access our Medtech Brexit coverage

Get free access to all our Brexit coverage
Get free access to all our Brexit coverage

Get free access to all our Brexit coverage
Pharma Brexit podcast
Pharma Brexit podcast

Podcasts

Listen to our Pharma and Medtech Brexit podcasts 

Pharma Brexit podcast

Podcasts

Listen to our Pharma and Medtech Brexit podcasts 

Pharma Brexit podcast
-
UK's Brexit from EU
02/07/20
1
Pharma Brexit podcast
-
Higher Drug Prices Post-Brexit
12/04/19
1
Pharma Brexit podcast
-
Brexit, COVID-19 and NHS Reform
08/07/20
1
Pharma Brexit
Pharma Brexit

Pharma article pack

Download our Pharma Brexit coverage

Pharma Brexit

Pharma article pack

Download our Pharma Brexit coverage

Pharma Brexit
-
Pharma Brexit Article PackUK Unveils Go-It-Alone Drug Approval System
1
Pharma Brexit
-
Pharma Brexit Article PackBrexit: Life Science Firms In An ‘Impossible Position’
1
Pharma Brexit
-
Pharma Post Brexit Article Pack
Pfizer Holds Number One Spot And Takeda Breaks The Top 10
1
MedTech Brexit
MedTech Brexit

Medtech Article Pack

Download our Medtech Brexit coverage

MedTech Brexit

Medtech Article Pack

Download our Medtech Brexit coverage

MedTech Brexit
-
Medtech Brexit Article PackA Global Approach To Medtech Regulation: The Post-EU Way Ahead For UK Industry?
1
MedTech Brexit
-
Medtech Brexit Article Pack50 Days To Brexit – And No Extension, Govt Warns UK Medtechs
1
MedTech Brexit
-
Medtech Post Brexit Article PackUK All-Party Report Assesses Brexit Medtech Impact While Germany Worries Over Border Delays
1
newsletter-sign-up-logo

Register now for monthly Brexit updates

Collapse
Sign up here Expand